Journal of the Formosan Medical Association
Volume 109, Issue 5 , Pages 378-388 , May 2010

Symptomatic Resolution Among Chinese Patients With Schizophrenia and Associated Factors

  • Cheng-Ta Li

      Affiliations

    • Department of Psychiatry, Taipei Veterans General Hospital, National Yang-Ming University, Taipei, Taiwan
    • Division of Psychiatry, School of Medicine, National Yang-Ming University, Taipei, Taiwan
    • ,
  • Tung-Ping Su

      Affiliations

    • Department of Psychiatry, Taipei Veterans General Hospital, National Yang-Ming University, Taipei, Taiwan
    • Division of Psychiatry, School of Medicine, National Yang-Ming University, Taipei, Taiwan
    • ,
  • Yuan-Hwa Chou

      Affiliations

    • Department of Psychiatry, Taipei Veterans General Hospital, National Yang-Ming University, Taipei, Taiwan
    • Division of Psychiatry, School of Medicine, National Yang-Ming University, Taipei, Taiwan
    • ,
  • Ying-Chiao Lee

      Affiliations

    • Department of Psychiatry, Taipei Veterans General Hospital, National Yang-Ming University, Taipei, Taiwan
    • Division of Psychiatry, School of Medicine, National Yang-Ming University, Taipei, Taiwan
    • ,
  • Mu-En Liu

      Affiliations

    • Department of Psychiatry, Taipei Veterans General Hospital, National Yang-Ming University, Taipei, Taiwan
    • ,
  • Hsiao-Lun Ku

      Affiliations

    • Department of Psychiatry, Taipei Veterans General Hospital, National Yang-Ming University, Taipei, Taiwan
    • ,
  • Ian-Kai Shan

      Affiliations

    • Department of Psychiatry, Taipei Veterans General Hospital, National Yang-Ming University, Taipei, Taiwan
    • ,
  • Ya-Mei Bai

      Affiliations

    • Department of Psychiatry, Taipei Veterans General Hospital, National Yang-Ming University, Taipei, Taiwan
    • Division of Psychiatry, School of Medicine, National Yang-Ming University, Taipei, Taiwan
    • Corresponding Author InformationCorrespondence to: Dr Ya-Mei Bai, Department of Psychiatry, Taipei Veterans General Hospital, 201 Shih-Pai Road Section 2, Taipei 11217, Taiwan

Received 1 March 2009 ,Revised 24 May 2009 ,Accepted 22 August 2009.

References 

  1. Jobe TH , Harrow M . Long-term outcome of patients with schizophrenia: a review . Can J Psychiatry . 2005;50:892–900
  2. Amminger GP , Resch F , Mutschlechner R , et al.   Premorbid adjustment and remission of positive symptoms in firstepisode psychosis . Eur Child Adolesc Psychiatry . 1997;6:212–218
  3. Curtis CE , Calkins ME , Grove WM , et al.   Saccadic disinhibition in patients with acute and remitted schizophrenia and their first-degree biological relatives . Am J Psychiatry . 2001;158:100–106
  4. Eaton WW , Thara R , Federman E , et al.   Remission and relapse in schizophrenia: the Madras Longitudinal Study . J Nerv Ment Dis . 1998;186:357–363
  5. Lieberman J , Jody D , Geisler S , et al.   Time course and biologic correlates of treatment response in first-episode schizophrenia . Arch Gen Psychiatry . 1993;50:369–376
  6. Auslander LA , Jeste DV . Sustained remission of schizophrenia among community-dwelling older outpatients . Am J Psychiatry . 2004;161:1490–1493
  7. Leucht S , Lasser R . The concepts of remission and recovery in schizophrenia . Pharmacopsychiatry . 2006;39:161–170
  8. Andreasen NC , Carpenter WT , Kane JM , et al.   Remission in schizophrenia: proposed criteria and rationale for consensus . Am J Psychiatry . 2005;162:441–449
  9. Kay SR , Fiszbein A , Opler LA . The positive and negative syndrome scale (PANSS) for schizophrenia . Schizophr Bull . 1987;13:261–276
  10. Helldin L , Kane JM , Karilampi U , et al.   Remission and cognitive ability in a cohort of patients with schizophrenia . J Psychiatr Res . 2006;40:738–745
  11. Helldin L , Kane JM , Karilampi U , et al.   Remission in prognosis of functional outcome: a new dimension in the treatment of patients with psychotic disorders . Schizophr Res . 2007;93:160–168
  12. van Os J , Drukker M , a Campo J , et al.   Validation of remission criteria for schizophrenia . Am J Psychiatry . 2006;163:2000–2002
  13. Docherty JP , Bossie CA , Lachaux B , et al.   Patient-based and clinician-based support for the remission criteria in schizophrenia . Int Clin Psychopharmacol . 2007;22:51–55
  14. Lasser RA , Nasrallah H , Helldin L , et al.   Remission in schizophrenia: applying recent consensus criteria to refine the concept . Schizophr Res . 2007;96:223–231
  15. Emsley R , Rabinowitz J , Medori R . Remission in early psychosis: rates, predictors, and clinical and functional outcome correlates . Schizophr Res . 2007;89:129–139
  16. De Hert M , van Winkel R , Wampers M , et al.   Remission criteria for schizophrenia: evaluation in a large naturalistic cohort . Schizophr Res . 2007;92:68–73
  17. Peuskens J , Kaufman L , Van Vleymen B . Analysis of resolution criteria in patients with schizophrenia treated with olanzapine for an acute psychotic episode . Schizophr Res . 2007;95:169–173
  18. Lasser RA , Bossie CA , Gharabawi GM , et al.   Remission in schizophrenia: results from a 1-year study of long-acting risperidone injection . Schizophr Res . 2005;77:215–227
  19. San L , Ciudad A , Alvarez E , et al.   Symptomatic remission and social/vocational functioning in outpatients with schizophrenia: prevalence and associations in a cross-sectional study . Eur Psychiatry . 2007;8:490–498
  20. Zimmermann PaFB . Test for Attentional Performance (TAP) . Freiburg: Psytest Press; 1997;
  21. Liu SK , Chiu CH , Chang CJ , et al.   Deficits in sustained attention in schizophrenia and affective disorders: stable versus state-dependent markers . Am J Psychiatry . 2002;159:975–982
  22. Tsuang HC , Lin SH , Liu SK , et al.   More severe sustained attention deficits in nonpsychotic siblings of multiplex schizophrenia families than in those of simplex ones . Schizophr Res . 2006;87:172–180
  23. Krishnadas R , Moore BP , Nayak A , et al.   Relationship of cognitive function in patients with schizophrenia in remission to disability: a cross-sectional study in an Indian sample . Ann Gen Psychiatry . 2007;6:19
  24. Hintze B , Kuhn-Dymecka A , Bembenek A , et al.   Attention impairment in patients suffering from schizophrenia and their relatives of first-degree . Psychiatr Pol . 2004;38:861–873 [In Polish]
  25. Liu SK , Chen WJ , Chang CJ , et al.   Effects of atypical neuroleptics on sustained attention deficits in schizophrenia: a trial of risperidone versus haloperidol . Neuropsychopharmacology . 2000;22:311–319
  26. American Psychiatric Association  . Diagnostic and Statistical Manual of Mental Disorders . 4th Edition. Washington: American Psychiatric Association; 1994;
  27. Cheng JJ , Ho H , Chang CJ , et al.   Positive and Negative Syndrome Scale (PANSS): establishment and reliability study of a Mandarin Chinese language version . Chin Psychiatry . 1996;10:251–258
  28. Lingjaerde O , Ahlfors UG , Bech P , et al.   The UKU side effect rating scale. A new comprehensive rating scale for psychotropic drugs and a cross-sectional study of side effects in neuroleptic-treated patients . Acta Psychiatr Scand Suppl . 1987;334:1–100
  29. Psychopharmacology Research Branch NIoMH  . Abnormal Involuntary Movement Scale (AIMS) . In:  Guy W editors. ECDEU Assessment Manual for Psychopharmacology, Revised. US Dept Health, Education, and Welfare publication (ADM) 76-338 . Rockville, MD: National Institute of Mental Health; 1976;
  30. Simpson GM , Angus JW . A rating scale for extrapyramidal side effects . Acta Psychiatr Scand Suppl . 1970;212:11–19
  31. Jenkinson C , Layte R , Jenkinson D , et al.   A shorter form health survey: can the SF-12 replicate results from the SF-36 in longitudinal studies? . J Public Health Med . 1997;19:179–186
  32. Naber D , Moritz S , Lambert M , et al.   Improvement of schizophrenic patients' subjective well-being under atypical antipsychotic drugs . Schizophr Res . 2001;50:79–88
  33. Sim K , Chuan SuH , Fujii S , et al.   Low doses of antipsychotic drugs for hospitalized schizophrenia patients in East Asia: 2004 vs. 2001 . Int J Neuropsychopharmacol . 2009;12:117–123
  34. Emsley RA , Roberts MC , Rataemane S , et al.   Ethnicity and treatment response in schizophrenia: a comparison of 3 ethnic groups . J Clin Psychiatry . 2002;63:9–14
  35. Bhugra D . Severe mental illness across cultures . Acta Psychiatr Scand Suppl . 2006;429:17–23
  36. San L , Ciudad A , Alvarez E , et al.   Symptomatic remission and social/vocational functioning in outpatients with schizophrenia: prevalence and associations in a cross-sectional study . Eur Psychiatry . 2007;22:490–498
  37. Haddad PM , Sharma SG . Adverse effects of atypical antipsychotics: differential risk and clinical implications . CNS Drugs . 2007;21:911–936
  38. Hamer S , Haddad PM . Adverse effects of antipsychotics as outcome measures . Br J Psychiatry Suppl . 2007;50:S64–S70
  39. Lieberman JA . Effectiveness of antipsychotic drugs in patients with chronic schizophrenia: efficacy, safety and cost outcomes of CATIE and other trials . J Clin Psychiatry . 2007;68:e04
  40. Sharif Z . Side effects as influencers of treatment outcome . J Clin Psychiatry . 2008;69(Suppl 3):38–43
  41. Leucht S , Corves C , Arbter D , et al.   Second-generation versus first-generation antipsychotic drugs for schizophrenia: a meta-analysis . Lancet . 2009;373:31–41
  42. Ciudad A , Alvarez E , Bobes J , et al.   Remission in schizophrenia: results from a 1-year follow-up observational study . Schizophr Res . 2009;108:214–222
  43. Johnsen E , Jorgensen HA . Effectiveness of second generation antipsychotics: a systematic review of randomized trials . BMC Psychiatry . 2008;8:31
  44. Luft B , Taylor D . A review of atypical antipsychotic drugs versus conventional medication in schizophrenia . Expert Opin Pharmacother . 2006;7:1739–1748
  45. van Os J , Burns T , Cavallaro R , et al.   Standardized remission criteria in schizophrenia . Acta Psychiatr Scand . 2006;113:91–95
  46. Crespo-Facorro B , Rodriguez-Sanchez JM , Perez-Iglesias R , et al.   Neurocognitive effectiveness of haloperidol, risperidone, and olanzapine in first-episode psychosis: a randomized, controlled 1-year follow-up comparison . J Clin Psychiatry . 2009;70:717–729
  47. Szoke A , Trandafir A , Dupont ME , et al.   Longitudinal studies of cognition in schizophrenia: meta-analysis . Br J Psychiatry . 2008;192:248–257

PII: S0929-6646(10)60066-6

doi: 10.1016/S0929-6646(10)60066-6

Journal of the Formosan Medical Association
Volume 109, Issue 5 , Pages 378-388 , May 2010

Article Tools